肺癌早期诊断；靶向治疗；免疫治疗；综合治疗；耐药机制
Early diagnosis of lung cancer; targeted therapy; immunotherapy; comprehensive treatment and drug resistance mechanisms
同济大学附属上海市肺科医院肿瘤科行政主任
同济大学医学院肿瘤研究所所长
同济大学肿瘤学系主任
国际肺癌研究协会董事会核心成员
CSCO非小细胞肺癌专委会主任委员
中国医促会胸部肿瘤分会主任委员
上海市抗癌协会肺癌肺癌靶向和免疫治疗专委会主任委员
中国抗癌协会肿瘤药物临床研究专委会候任主委
CSCO肿瘤转化医学专业委员会候任主委
中国抗癌协会肺癌专业委员会常务委员
中国医师学会肿瘤医师分会常务委员
国际肺癌联盟（IASLC）控烟委员会委员
上海市医师协会肿瘤专科医师分会副会长
Executive Director of Oncology Department of Shanghai Pulmonary Hospital Affiliated to Tongji University
Director of Oncology Research Institute of Tongji University School of Medicine
Director of Oncology Department of Tongji University
Board of Director in International Association for the Study of Lung Cancer
Chairman of CSCO Non-Small Cell Lung Cancer Special Committee
Chairman of the Thoracic Oncology Branch of CPAM
Chairman of the Shanghai Anti-Cancer Association Lung Cancer Targeting and Immunotherapy Committee
Chairman-designate of the Chinese Anti-Cancer Association Cancer Drug Clinical Research Committee
Chairman-designate of CSCO Translational Tumor Medicine Professional Committee
Standing member of the Lung Cancer Professional Committee of the Chinese Anti-Cancer Association
Standing member of the Oncologist Branch of the Chinese Medical Doctor Association
Member of IASLC Tobacco Control Committee,Vice President of Oncology Specialist Branch of Shanghai Medical Doctor Association.
主要致力于肺癌早期诊断、靶向治疗、免疫治疗、耐药机制等方面的研究。先后承担国家863、国家自然科学基金、上海市科委重大攻关等项目。在国内外刊物上发表论著200余篇，其中发表包括Lancet Oncology, JCO，Annals of Oncology, JTO，Cancer等在内SCI论文100余篇。并具有领导多中心临床研究经验，先后主持或参与30余项国内多中心肺癌临床研究。
Prof. Zhou focuses on research of the molecular biology of lung cancer and individualized treatment of cancer. Received Research funds from Chinse government including national 863 project from the minister of Science and Technology, National Natural Science Foundation of China, key project funds from the Science and Technology Commission of Shanghai Municipality. He has published more than 200 articles in domestic and foreign journals, including more than 100 SCI papers including Lancet Oncology, JCO, Annals of Oncology, JTO and Cancer. Took part in or initiated more than 30 clinical trials in the field of lung cancer.
